Sih-han Chen
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
EPS8 Differentially Regulates Antioxidant Defense and Mitochondrial Homeostatic Signaling in LNCaP and Enzalutamide-resistant LNCaP Cells.
Journal: Cancer genomics & proteomics
Published: June 08, 2026
Verbascoside Suppresses Epithelial-Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer.
Journal: Cancer genomics & proteomics
Published: May 29, 2025
Rutin Suppresses EMT and Induces Mitochondrial Biogenesis via ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells.
Journal: Cancer genomics & proteomics
Published: April 28, 2025
SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate Cancer.
Journal: Cancer genomics & proteomics
Published: April 28, 2025
Phillyrin Modulates AMPK-Associated Cellular Responses and Migration in PC3 Prostate Cancer Cells.
Journal: Journal of toxicology
Published: February 12, 2025
Knockdown of EPS8 expression attenuates the proliferation of enzalutamide-resistant prostate cancer cells.
Journal: American journal of cancer research
Published: March 27, 2024
A cost-effective transperineal prostate biopsy method utilizes the original transrectal setting.
Journal: International urology and nephrology
Published: May 23, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026